Published in Biochem J on July 01, 1993
Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature (1970) 1528.65
A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem (1976) 903.81
ras genes. Annu Rev Biochem (1987) 22.59
The GTPase superfamily: conserved structure and molecular mechanism. Nature (1991) 19.64
Oncogenes and signal transduction. Cell (1991) 14.84
Inhibitory effect of a marine-sponge toxin, okadaic acid, on protein phosphatases. Specificity and kinetics. Biochem J (1988) 8.02
Phospholipase C-gamma is a substrate for the PDGF and EGF receptor protein-tyrosine kinases in vivo and in vitro. Cell (1989) 6.88
Requirement for ras proto-oncogene function during serum-stimulated growth of NIH 3T3 cells. Nature (1985) 6.41
cdc25 is a specific tyrosine phosphatase that directly activates p34cdc2. Cell (1991) 6.32
Early signals in the mitogenic response. Science (1986) 5.89
Distinct phosphotyrosines on a growth factor receptor bind to specific molecules that mediate different signaling pathways. Cell (1992) 5.09
Direct activation of the serine/threonine kinase activity of Raf-1 through tyrosine phosphorylation by the PDGF beta-receptor. Cell (1989) 4.86
PDGF beta-receptor stimulates tyrosine phosphorylation of GAP and association of GAP with a signaling complex. Cell (1990) 4.85
Dephosphorylation and activation of a p34cdc2/cyclin B complex in vitro by human CDC25 protein. Nature (1991) 4.54
The cdc25 protein contains an intrinsic phosphatase activity. Cell (1991) 4.39
PDGF induction of tyrosine phosphorylation of GTPase activating protein. Nature (1989) 4.36
Effects of the tumour promoter okadaic acid on intracellular protein phosphorylation and metabolism. Nature (1989) 4.27
Role of phosphatidylinositol kinase in PDGF receptor signal transduction. Science (1989) 4.21
Presence of an SH2 domain in the actin-binding protein tensin. Science (1991) 4.03
Ribosome gymnastics--degree of difficulty 9.5, style 10.0. Cell (1990) 4.01
Signal transduction by the platelet-derived growth factor receptor. Science (1989) 3.94
Binding of GAP to activated PDGF receptors. Science (1990) 3.89
Signal transduction from membrane to cytoplasm: growth factors and membrane-bound oncogene products increase Raf-1 phosphorylation and associated protein kinase activity. Proc Natl Acad Sci U S A (1988) 3.52
A protein-tyrosine phosphatase with sequence similarity to the SH2 domain of the protein-tyrosine kinases. Nature (1991) 2.80
Phosphorylation sites in the PDGF receptor with different specificities for binding GAP and PI3 kinase in vivo. EMBO J (1992) 2.79
ras GTPase activating protein: signal transmitter and signal terminator. Cell (1989) 2.78
Platelet-derived growth factor induces rapid and sustained tyrosine phosphorylation of phospholipase C-gamma in quiescent BALB/c 3T3 cells. Mol Cell Biol (1989) 2.78
Platelet-derived growth factor (PDGF) binding promotes physical association of PDGF receptor with phospholipase C. Proc Natl Acad Sci U S A (1989) 2.75
Platelet-derived growth factor (PDGF)-dependent association of phospholipase C-gamma with the PDGF receptor signaling complex. Mol Cell Biol (1990) 2.71
corkscrew encodes a putative protein tyrosine phosphatase that functions to transduce the terminal signal from the receptor tyrosine kinase torso. Cell (1992) 2.69
Platelet-derived growth factor receptors form a high affinity state in membrane preparations. Kinetics and affinity cross-linking studies. J Biol Chem (1984) 2.61
Use of vanadate as protein-phosphotyrosine phosphatase inhibitor. Methods Enzymol (1991) 2.59
Modulation of guanine nucleotides bound to Ras in NIH3T3 cells by oncogenes, growth factors, and the GTPase activating protein (GAP). J Biol Chem (1990) 2.49
Growth factors in development, transformation, and tumorigenesis. Cell (1991) 2.49
Platelet-derived growth factor stimulates formation of active p21ras.GTP complex in Swiss mouse 3T3 cells. Proc Natl Acad Sci U S A (1990) 2.26
The cdc25 M-phase inducer: an unconventional protein phosphatase. Cell (1992) 2.12
Molecular analysis of signal transduction by growth factors. Biochemistry (1988) 2.07
An additional homolog of the fission yeast cdc25+ gene occurs in humans and is highly expressed in some cancer cells. New Biol (1991) 2.04
Protein-tyrosine phosphatases: the other side of the coin. Cell (1989) 1.92
Tyrosine phosphorylation in T cells is regulated by phosphatase activity: studies with phenylarsine oxide. Proc Natl Acad Sci U S A (1990) 1.80
ras p21 and GAP inhibit coupling of muscarinic receptors to atrial K+ channels. Cell (1990) 1.67
Opposing effects of a ras oncogene on growth factor-stimulated phosphoinositide hydrolysis: desensitization to platelet-derived growth factor and enhanced sensitivity to bradykinin. Proc Natl Acad Sci U S A (1987) 1.52
Tyrosine mutations within the alpha platelet-derived growth factor receptor kinase insert domain abrogate receptor-associated phosphatidylinositol-3 kinase activity without affecting mitogenic or chemotactic signal transduction. Mol Cell Biol (1991) 1.42
Protein tyrosine dephosphorylation and signal transduction. Trends Biochem Sci (1989) 1.37
Loss of platelet-derived growth factor-stimulated phospholipase activity in NIH-3T3 cells expressing the EJ-ras oncogene. Proc Natl Acad Sci U S A (1987) 1.31
GTPase-activating protein SH2-SH3 domains induce gene expression in a Ras-dependent fashion. Mol Cell Biol (1992) 1.29
The ras superfamily of small GTP-binding proteins. Trends Biochem Sci (1990) 1.21
Identification, purification, and characterization of phosphotyrosine-specific protein phosphatases from cultured chicken embryo fibroblasts. Mol Cell Biol (1984) 1.16
Clues to action of cdc25 protein. Nature (1991) 1.13
The biochemistry of ras p21. Biochem J (1991) 1.08
NIH-3T3 cells transformed by the EJ-ras oncogene exhibit reduced platelet-derived growth factor-mediated Ca2+ mobilization. Proc Natl Acad Sci U S A (1988) 1.04
Insulin-induced p21ras activation does not require protein kinase C, but a protein sensitive to phenylarsine oxide. J Biol Chem (1991) 1.04
P21 v-ras inhibits induction of c-myc and c-fos expression by platelet-derived growth factor. Mol Cell Biol (1988) 1.03
Regulation of protein phosphotyrosine content by changes in tyrosine kinase and protein phosphotyrosine phosphatase activities during induced granulocytic and monocytic differentiation of HL-60 leukemia cells. Biochem Biophys Res Commun (1986) 0.93
Inhibition of platelet-derived growth factor-mediated signal transduction by transforming ras. Suppression of receptor autophosphorylation. J Biol Chem (1991) 0.92
Platelet-derived growth factor does not induce c-fos in NIH 3T3 cells expressing the EJ-ras oncogene. Mol Cell Biol (1988) 0.85
Scrape-loaded p21ras down-regulates agonist-stimulated inositol phosphate production by a mechanism involving protein kinase C. Biochem J (1989) 0.82
Dissociation of platelet-derived growth factor (PDGF) receptor autophosphorylation from other PDGF-mediated second messenger events. J Biol Chem (1991) 0.79
A phosphotyrosine displacement mechanism for activation of Src by PTPalpha. EMBO J (2000) 1.90
Glycolysis and methylaminoisobutyrate uptake in rat-1 cells transfected with ras or myc oncogenes. Proc Natl Acad Sci U S A (1985) 1.58
Stimulation of glycolysis and amino acid uptake in NRK-49F cells by transforming growth factor beta and epidermal growth factor. Proc Natl Acad Sci U S A (1985) 1.51
Nonradioactive determination of Ras-GTP levels using activated ras interaction assay. Methods Enzymol (2001) 1.23
Borderline and schizotypal personality disorders treated with low-dose thiothixene vs placebo. Arch Gen Psychiatry (1986) 0.99
Regulation of 6-phosphofructo-1-kinase activity in ras-transformed rat-1 fibroblasts. Arch Biochem Biophys (1991) 0.99
Participation of 5'-terminal leader sequences in in vitro translation of Rous sarcoma virus RNA. J Biol Chem (1982) 0.97
Suppression of platelet-derived growth factor receptor tyrosine kinase activity by unsaturated fatty acids. J Biol Chem (1993) 0.89
Diagnoses of the relatives of schizotypal outpatients. J Nerv Ment Dis (1986) 0.84
Attention deficits in newly abstinent substance abusers: childhood recollections and attention performance in thirty-nine subjects. J Addict Dis (1993) 0.80
Effect of growth factors and methionine on glycolysis and methionine transport in rat fibroblasts and fibroblasts transfected with myc and ras genes. Cancer Res (1986) 0.77
Role of N6-methyladenosine in expression of Rous sarcoma virus RNA: analyses utilizing immunoglobulin specific for N6-methyladenosine. Prog Nucleic Acid Res Mol Biol (1983) 0.77
Multiple modes of catalysis-dependent inhibition and inactivation of aortic lysyl oxidase. Arch Biochem Biophys (1983) 0.76
Enrichment of yeast protein tyrosine kinase activity by substrate affinity chromatography. Yeast (1996) 0.76
Differential prediction of response to thiothixene and placebo in borderline and schizotypal personality disorders. Psychopharmacol Bull (1987) 0.75
Treatment of an extensive odontogenic keratocyst by mandibular resection and immediate bone graft. J Conn State Dent Assoc (1980) 0.75
Effects of diagnostic criteria on incidence figures for schizophrenia. Am J Psychiatry (1978) 0.75
The impact of borderline and schizotypal personality disorders on patients and their families. Hosp Community Psychiatry (1985) 0.75
Borderline personality disorder: symptomatology and MMPI characteristics. J Clin Psychiatry (1983) 0.75
Behavior modification in the treatment of rumination. Clin Pediatr (Phila) (1983) 0.75